Coherus BioSciences
CHRS
$2.15
Share price
0.00%
Change (1 day)
-73.88%
Change (1 year)
Categories
Market capitalization of Coherus BioSciences (CHRS)
Market cap: $0.24 Billion
As of April 2024 Coherus BioSciences has a market cap of $0.24 Billion. This makes Coherus BioSciences the world's 6743th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Coherus BioSciences from 2014 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.24 B | -34.2% |
| 2023 | $0.37 B | -39.8% |
| 2022 | $0.61 B | -49.73% |
| 2021 | $1.22 B | -2.13% |
| 2020 | $1.25 B | -1.16% |
| 2019 | $1.26 B | 104.96% |
| 2018 | $0.61 B | 19.62% |
| 2017 | $0.51 B | -57.95% |
| 2016 | $1.22 B | 37.21% |
| 2015 | $0.89 B | 65% |
| 2014 | $0.54 B |
End of Day market cap according to different sources
On Apr 17th, 2024 the market cap of Coherus BioSciences was reported to be:
$0.24 Billion
$0.24 Billion
$0.24 Billion
$0.24 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $142.40 B | 58,257.55% | 🇺🇸 USA |
 Repligen
RGEN | $8.98 B | 3,583.66% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.82 M | -99.66% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | $6.16 B | 2,426.56% | 🇺🇸 USA |